16:33 EDT Aslan Pharmaceuticals files to sell 61.9M ordinary shares for holders
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASLN:
- Aslan Pharmaceuticals Amends Loan Conversion Terms
- ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the American Thoracic Society International Conference
- Aslan Pharmaceuticals presents data on eblasakimab as ATS conference
- ASLAN Pharmaceuticals Excels in Eblasakimab Trials
- Aslan Pharmaceuticals reports Q1 EPS (53c) vs. ($1.29) last year